BDBM237383 US10052306, 199::rac-6-{2-[(3aR,5R,6aS)- 5-hydroxy-5-[(4- methoxyphenyl)methyl]- octahydrocyclopenta[c] pyrrol-2-yl]-1- hydroxyethyl}pyridin-3- ol

SMILES COc1ccc(C[C@@]2(O)C[C@@H]3CN(CC(O)c4ccc(O)cn4)C[C@@H]3C2)cc1

InChI Key InChIKey=AJDQHGPZJKUZLQ-WDODAKIKSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 237383   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM237383(US10052306, 199 | rac-6-{2-[(3aR,5R,6aS)- 5-hydrox...)
Affinity DataIC50:  36.3nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent